At the American Society of Clinical Oncology (ASCO) annual meeting held in Chicago last year, a significant highlight was the presentation of a clinical trial conducted exclusively in China. This year, the conference will again feature a presentation focused on drug development from China.
✓ AI-Debiased Article
15
Public broadcaster
provisional
China's Drug Development Gains Attention at ASCO Annual Meeting
The ASCO annual meeting in Chicago last year showcased a clinical trial conducted in China, which is set to be a key presentation again this year. This highlights the growing prominence of China's role in drug development.
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
China’s Rise in Drug Development Looms Over U.S.
Neutral Headline
China's Drug Development Gains Attention at ASCO Annual Meeting